featured
Circulating Tumor DNA as a Biomarker for Treatment Failure in DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating Tumour DNA and CT Monitoring in Patients With Untreated Diffuse Large B-Cell Lymphoma: A Correlative Biomarker Study
Lancet Oncol 2015 Apr 01;[EPub Ahead of Print], M Roschewski, K Dunleavy, S Pittaluga, M Moorhead, F Pepin, K Kong, M Shovlin, ES Jaffe, LM Staudt, C Lai, SM Steinberg, CC Chen, J Zheng, TD Willis, M Faham, WH WilsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.